A study of AMC6156 for people with muscle loss
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 65 or older, or a woman who has gone through menopause
- You have been diagnosed with sarcopenia based on muscle mass measurements and either weak grip strength or reduced physical function
- Your body weight is at least 35 kg (about 77 lbs) and your BMI is between 15 and 30
- You are able to follow exercise and diet recommendations
- You do not have serious medical conditions like uncontrolled diabetes, heart disease, or advanced lung disease
- You have not had recent fractures or surgeries that affect your ability to walk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medicine called PLH-2301 to see if it can help improve muscle strength and function in people with age-related muscle loss (sarcopenia). It may be an option if you are 65 or older, have been diagnosed with sarcopenia, and can walk on your own.
This trial tests a combined exercise and nutrition program to help older adults with sarcopenia (muscle loss). It aims to improve muscle strength and function, especially for those with metabolic syndrome.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
This trial studies whether a structured exercise and nutrition program can improve muscle health in older adults with (pre)sarcopenia, especially those who may have slower walking or reduced strength. It also checks safety by excluding people with unstable health problems and several specific medical conditions.
This trial tests whether a combination of a vitamin D-like drug (idecalcitol), whey protein powder, and a structured exercise program can help rebuild muscle strength and mass in people with sarcopenia. It lasts about 6 months.
This study tests a new capsule called TJ0113 to see if it can help older adults with sarcopenia (muscle loss) improve their muscle strength and physical function. It's a phase 2 study, meaning the drug is being tested for safety and effectiveness.
Hear when a new Sarcopenia in Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.